We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 21, 2021

Convalescent Plasma Therapy and Survival in Patients With Hematologic Cancers and COVID-19

JAMA Oncology


Additional Info

JAMA Oncology
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
JAMA Oncol 2021 Jun 17;[EPub Ahead of Print], MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, TK Choueiri, DB Flora, EA Griffiths, AP Gulati, C Hwang, VS Koshkin, EB Papadopoulos, EV Robilotti, CT Su, EM Wulff-Burchfield, Z Xie, PP Yu, S Mishra, JW Senefeld, DP Shah, JL Warner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading